|
|
||||||||
Papers In Press, published online ahead of print September 1, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on June 28, 2002
Inserm U539, Nantes, Cedex 01 44093
Corresponding Author: maud.chetiveaux{at}sante.univ-nantes.fr
The aim of the study was to assess the isolation of HDL by Fast Protein Liquid Chromatography (FPLC) to perform kinetics studies of Apo A-I-HDL labelled with a stable isotope. Comparison between FPLC and ultracentrifugation have been made. Apo A-I-HDL kinetics were studied by infusion of [5.5.5-2H3]-leucine for 14 hours in five subjects. Using FPLC, preb1 HDL and aHDL (HDL2 and HDL3) were separated from 200µl of plasma samples. Total HDL were isolated by sequential ultracentrifugation (HDL-UC). The tracer-to-tracee ratio were higher in preb1 HDL than in total HDL-UC. The higher leucine enrichment found in total HDL-UC compared to aHDL suggested the existence of a mixture of Apo A-I-HDL sub-classes. From this difference in enrichments, the turnover rate of total HDL-UC, usually assumed to be aHDL was probably overestimated in previous studies. To our knowledge, this study is the first report which provides a convenient tool to distinguish enrichments of Apo A-I in preb1 HDL and aHDL from total HDL previously used for kinetic measurements. This original and new method should help to understand the kinetics of HDL in humans and the reverse cholesterol transport dynamics.
Revised on September 1, 2002
Accepted on August 20, 2002
The differential apolipoprotein A-I enrichment of preb1 and alpha-HDL is detectable by gel filtration separation
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
J. White, T. Guerin, H. Swanson, S. Post, H. Zhu, M. Gong, J. Liu, W. V. Everson, X.-A. Li, G. A. Graf, et al. Diabetic HDL-associated myristic acid inhibits acetylcholine-induced nitric oxide generation by preventing the association of endothelial nitric oxide synthase with calmodulin Am J Physiol Cell Physiol, January 1, 2008; 294(1): C295 - C305. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Berrougui, M. Isabelle, M. Cloutier, G. Grenier, and A. Khalil Age-related impairment of HDL-mediated cholesterol efflux J. Lipid Res., February 1, 2007; 48(2): 328 - 336. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rashid, B. W. Patterson, and G. F. Lewis Thematic review series: Patient-Oriented Research. What have we learned about HDL metabolism from kinetics studies in humans? J. Lipid Res., August 1, 2006; 47(8): 1631 - 1642. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ouguerram, M. Chetiveaux, Y. Zair, P. Costet, M. Abifadel, M. Varret, C. Boileau, T. Magot, and M. Krempf Apolipoprotein B100 Metabolism in Autosomal-Dominant Hypercholesterolemia Related to Mutations in PCSK9 Arterioscler. Thromb. Vasc. Biol., August 1, 2004; 24(8): 1448 - 1453. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Sviridov, B. Kingwell, A. Hoang, A. Dart, and P. Nestel Single session exercise stimulates formation of pre{beta}1-HDL in leg muscle J. Lipid Res., March 1, 2003; 44(3): 522 - 526. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |